Novel coronavirus pneumonia prevention and control system and medical treatment were introduced in March 24th. Wang Rongbing, chief physician of the Department of integrated traditional and Western medicine of Beijing Ditan Hospital Affiliated to Capital Medical University, attended the meeting to respond to the media's concerns about the advantages of traditional Chinese medicine in the rehabilitation of patients, the clinical application of Qingfei Paidu Decoction and the progress of scientific research.

Wang Rongbing said that the rehabilitation treatment is the traditional and characteristic of traditional Chinese medicine. At present, there are rehabilitation stations and TCM rehabilitation clinics in Wuhan. Outside Wuhan, TCM rehabilitation clinics can meet the needs of patients. For severe and critical patients with lung function impairment and pulmonary fibrosis, Wang Rongbing said that early intervention of traditional Chinese medicine should be allowed. On the basis of previous research, according to the achievements of major special projects and national major scientific research projects, traditional Chinese medicine can be used to provide long-term treatment for patients.

With regard to the clinical application and scientific research progress of qingfeipaidu decoction, Wang Rongbing said that qingfeipaidu decoction has been used in 28 provinces (regions and cities) in China. As of March 23, of the 1265 confirmed patients enrolled in the observation in 66 designated hospitals in 10 provinces other than Hubei, none of them turned from light to heavy, and none of them turned from common to critical. More than 98% of 1241 patients were cured and discharged. In clinical observation, 57 cases of severe patients were treated with Qingfei Paidu decoction, none of them turned to critical illness, 42 of them were cured and discharged from hospital, no liver and kidney injury was found.

At present, the research on the medicinal mechanism and material basis of qingfeipaidu decoction is under intense progress. Novel coronavirus pneumonia was recently published in Chinese medicine journal. The mechanism of Qingfei detoxification Decoction in treating new crown pneumonia was discussed from molecular network level. Naval Medical University, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Peking University research team, etc. also carried out the discussion of effective substances from multiple perspectives, and studied and analyzed the target channel and mechanism of action. It has been found that the 21 traditional Chinese medicine guifeijing of this prescription has predicted 790 potential targets, focusing on biological processes such as immunity, anti-inflammatory, endocrine, signal transduction, etc., which can inhibit the production of bacterial endotoxin, promote the expression of anti-inflammatory factor IL10, not inhibit the activity of macrophages, and alleviate the inflammatory storm. The Chinese Academy of traditional Chinese medicine has completed the research on the quality standard, production process and safety of qingfeipaidu mixture. Four Chinese medicine enterprises have completed the research on the quality standard and production process of qingfeipaidu compound granules, aiming to make qingfeipaidu Decoction better serve the anti epidemic situation and clinical treatment.

Source：http://www.cntcm.com.cn/2020-03/25/content_72746.htm

Time：2020-03-25